Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Julie Priest, Rachel H. Bhak, Maral Dersarkissian, Alan Oglesby, Colin Kunzweiler, Ellie Fuqua, Suna Park, Mei Sheng Duh & Cindy Garris. (2021) Retrospective analysis of adherence to HIV treatment and healthcare utilization in a commercially insured population. Journal of Medical Economics 24:1, pages 1204-1211.
Read now
Read now
Dereje Bayissa Demissie, Gizachew Abdissa Bulto, Wagi Tosisa Mekuria, Fikru Negassa Dufera & Eriste Nigussa Gamshe. (2020) Evaluation of Antiretroviral Therapy Initiated Among Pregnant Women Under Option B+ by Viral Load and CD4 Count Outcomes in Selected Hospitals of West Shewa Zone, Oromia Region, Ethiopia. HIV/AIDS - Research and Palliative Care 12, pages 127-134.
Read now
Read now
Carolina Dagli-Hernandez, Rosa Camila Lucchetta, Tales Rubens de Nadai, José Carlos Fernandez Galduróz & Patricia de Carvalho Mastroianni. (2016) Self-perception of knowledge and adherence reflecting the effectiveness of antiretroviral therapy. Patient Preference and Adherence 10, pages 1787-1793.
Read now
Read now
Ed L. Wilkins, Calvin J. Cohen, Benoit Trottier, Stefan Esser, Don E. Smith, Bernhard Haas, Cynthia Brinson, Will Garner, Susan Chuck, David Thorpe & Shampa De-Oertel. (2016) Patient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate in antiretroviral treatment-naive adults infected with HIV-1 through 48 weeks of treatment. AIDS Care 28:3, pages 401-408.
Read now
Read now
Nancy A. Hessol, Susan Holman, Howard Minkoff, Mardge H. Cohen, Elizabeth T. Golub, Seble Kassaye, Roksana Karim, Oluwakemi Sosanya, Christopher Shaheen & Zaher Merhi. (2016) Menstrual cycle phase and single tablet antiretroviral medication adherence in women with HIV. AIDS Care 28:1, pages 11-21.
Read now
Read now
Franco Maggiolo, Giorgio L Colombo, Sergio Di Matteo, Giacomo M Bruno, Noemi Astuti, Elisa Di Filippo, Giulia Masini & Claudia Bernardini. (2015) Cost-effectiveness analysis of antiretroviral therapy in a cohort of HIV-infected patients starting first-line highly active antiretroviral therapy during 6 years of observation. Patient Related Outcome Measures 6, pages 53-60.
Read now
Read now
Dolores García-Alonso, María Ángeles Muñoz-Fernández & J. Carlos González-Faraco. (2015) Living to suffer? Quality of life factors associated with adherence to antiretroviral therapy in Spanish HIV-infected children. Vulnerable Children and Youth Studies 10:2, pages 163-177.
Read now
Read now
Claudia Bernardini & Franco Maggiolo. (2013) Triple-combination rilpivirine, emtricitabine, and tenofovir (Complera™/Eviplera™) in the treatment of HIV infection. Patient Preference and Adherence 7, pages 531-542.
Read now
Read now
Jean B Nachega, Bernd Rosenkranz & Paul A Pham. (2011) Twice-daily versus once-daily antiretroviral therapy and coformulation strategies in HIV-infected adults: benefits, risks, or burden?. Patient Preference and Adherence 5, pages 645-651.
Read now
Read now
Articles from other publishers (51)
Marisa Brizzi, Elizabeth M. Sherman, Sarah B. Green, Diana N. Nowicki, Emily N. Drwiega, Melanie R. Nicol, Daniel B. Chastain, Eric G. Sahloff, William R. Truong, David Cluck, Melissa E. Badowski, Sarah M. Michienzi & Spencer H. Durham. (2023)
Personalizing prevention: Advances in pharmacotherapy for
HIV
prevention
. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 43:4, pages 305-320.
Crossref
Crossref
Gede Arya Bagus Arisudhana & Luh Putu Novi Artati. (2022) Korelasi Stigma dengan Lost To-Follow Up pada Orang Dengan HIV dan AIDS. Journal Nursing Research Publication Media (NURSEPEDIA) 1:3, pages 152-160.
Crossref
Crossref
Zahra Jaafari, Willi McFarland, Sana Eybpoosh, Seyed Vahid Ahmadi Tabatabaei, Mehdi Shafiei Bafti, Ebrahim Ranjbar & Hamid Sharifi. (2022) Barriers and facilitators of access to HIV prevention, care, and treatment services among people living with HIV in Kerman, Iran: a qualitative study. BMC Health Services Research 22:1.
Crossref
Crossref
MI Figueroa, A Camiro‐Zuñiga, PF Belaunzaran‐Zamudio, J Sierra Madero, J Andrade Villanueva, JR Arribas, JR Lama, DM Cecchini, G Lopardo, B Crabtree‐Ramírez, A Gun, P Patterson, VI Fink, OG Sued & P Cahn. (2020) The effect of protease inhibitor‐based dual antiretroviral regimens on CD4/CD8 ratio during the first year of therapy in ART‐naïve patients with HIV‐infection. HIV Medicine 22:4, pages 254-261.
Crossref
Crossref
Jason J Schafer, Neha S Pandit, Agnes Cha, Emily Huesgen, Melissa Badowski, Elizabeth M Sherman, Jennifer Cocohoba, Ayako Shimada & Scott W Keith. (2021) Incidence and Severity of Drug Interactions Before and After Switching Antiretroviral Therapy to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Treatment-Experienced Patients. Open Forum Infectious Diseases 8:1.
Crossref
Crossref
Pavan Vaddady, Bhargava Kandala & Ka Lai Yee. (2020) Population Pharmacokinetic and Pharmacodynamic Analysis To Evaluate a Switch to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate in People Living with HIV-1. Antimicrobial Agents and Chemotherapy 64:11.
Crossref
Crossref
Sarah Czarna Mann & Jose R. Castillo-Mancilla. (2020) HIV, aging, and adherence. Current Opinion in HIV and AIDS 15:2, pages 134-141.
Crossref
Crossref
Juan M. Leyva-Moral, Blanca K. Loayza-Enriquez, Patrick A. Palmieri, Genesis M. Guevara-Vasquez, Ursula E. Elias-Bravo, Joan E. Edwards, María Feijoo-Cid, Lucy Y. Davila-Olano, Juan R. Rodriguez-Llanos & Franco E. Leon-Jimenez. (2019) Adherence to antiretroviral therapy and the associated factors among people living with HIV/AIDS in Northern Peru: a cross-sectional study. AIDS Research and Therapy 16:1.
Crossref
Crossref
Leonardo Arévalo-Mora, Sonia Moscoso, Alcides Acosta & Mónica Mantilla. (2019) Complejidad de la transición de los esquemas antirretrovirales en un programa de atención de VIH en Bogotá durante el periodo de 2015-2017. Revista Colombiana de Ciencias Químico-Farmacéuticas 48:3.
Crossref
Crossref
Margaret Johnson, Princy Kumar, Jean-Michel Molina, Giuliano Rizzardini, Pedro Cahn, Markus Bickel, Josep Mallolas, Yan Zhou, Cristiana Morais, Sushma Kumar, Peter Sklar, George J. Hanna, Carey Hwang & Wayne Greaves. (2019) Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through 48 Weeks: Results of the DRIVE-SHIFT Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes 81:4, pages 463-472.
Crossref
Crossref
Tingting Jiang, Xin Zhou, Hui Wang, Mingyu Luo, Xiaohong Pan, Qiaoqin Ma & Lin Chen. (2019) Psychosocial Factors Associated with Quality of Life in Young Men Who Have Sex with Men Living with HIV/AIDS in Zhejiang, China. International Journal of Environmental Research and Public Health 16:15, pages 2667.
Crossref
Crossref
Rivka R. Lilian, Kate Rees, Moyahabo Mabitsi, James A. McIntyre, Helen E. Struthers & Remco P.H. Peters. (2019) Baseline CD4 and mortality trends in the South African human immunodeficiency virus programme: Analysis of routine data. Southern African Journal of HIV Medicine 20:1.
Crossref
Crossref
Alberto C. Guardo, Angela Zarama, Tania González, Manel Enric Bargalló, John Rojas, Esteban Martínez, Montserrat Plana & Sonsoles Sánchez-Palomino. (2019) Effects on immune system and viral reservoir of a short-cycle antiretroviral therapy in virologically suppressed HIV-positive patients. AIDS 33:6, pages 965-972.
Crossref
Crossref
James Ayieko, Lillian Brown, Sibyl Anthierens, Annelies Van Rie, Monica Getahun, Edwin D. Charlebois, Maya L. Petersen, Tamara D. Clark, Moses R. Kamya, Craig R. Cohen, Elizabeth A. Bukusi, Diane V. Havlir & Carol S. Camlin. (2018) “Hurdles on the path to 90-90-90 and beyond”: Qualitative analysis of barriers to engagement in HIV care among individuals in rural East Africa in the context of test-and-treat. PLOS ONE 13:8, pages e0202990.
Crossref
Crossref
Nimish Patel, Peter Borg, Richard Haubrich & Ian McNicholl. (2018) Analysis of drug–drug interactions among patients receiving antiretroviral regimens using data from a large open-source prescription database. American Journal of Health-System Pharmacy 75:15, pages 1132-1139.
Crossref
Crossref
Jesús Troya, Rocio Montejano, Pablo Ryan, Cristina Gómez, Mariano Matarranz, Alfonso Cabello, Francisco Vera, María Antonia Sepúlveda, Ignacio Santos, Gloria Samperiz, Pablo Bachiller, Vicente Boix, Pilar Barrufet, Miguel Cervero, José Sanz, Javier Solís, María Yllescas & Eulalia Valencia. (2018) Raltegravir plus abacavir/lamivudine in virologically suppressed HIV-1-infected patients: 48-week results of the KIRAL study. PLOS ONE 13:6, pages e0198768.
Crossref
Crossref
Jennifer Onwumeh, Charles I Okwundu & Tamara Kredo. (2017) Interleukin-2 as an adjunct to antiretroviral therapy for HIV-positive adults. Cochrane Database of Systematic Reviews 2017:5.
Crossref
Crossref
Yiyun Chen, Kun Chen & Seth C. Kalichman. (2016) Barriers to HIV Medication Adherence as a Function of Regimen Simplification. Annals of Behavioral Medicine 51:1, pages 67-78.
Crossref
Crossref
Daniel J. Feller & Bruce D. Agins. (2016) Understanding Determinants of Racial and Ethnic Disparities in Viral Load Suppression. Journal of the International Association of Providers of AIDS Care (JIAPAC) 16:1, pages 23-29.
Crossref
Crossref
John A. Sauceda, Mallory O. Johnson & Parya Saberi. (2016) Nonadherence as 4-day Antiretroviral Therapy Interruptions: Do Depression and Race/Ethnicity Matter as Much in the Modern Antiretroviral Therapy Era?. AIDS and Behavior 20:11, pages 2624-2628.
Crossref
Crossref
Jesús Troya, Pablo Ryan, Esteban Ribera, Daniel Podzamczer, Victor Hontañón, Jose Alberto Terrón, Vicente Boix, Santiago Moreno, Pilar Barrufet, Manuel Castaño, Ana Carrero, María José Galindo, Ignacio Suárez-Lozano, Hernando Knobel, Miguel Raffo, Javier Solís, María Yllescas, Herminia Esteban, Juan González-García, Juan Berenguer & Arkaitz Imaz. (2016) Abacavir/Lamivudine plus Rilpivirine Is an Effective and Safe Strategy for HIV-1 Suppressed Patients: 48 Week Results of the SIMRIKI Retrospective Study. PLOS ONE 11:10, pages e0164455.
Crossref
Crossref
Lesley S. Park, Janet P. Tate, Keith Sigel, David Rimland, Kristina Crothers, Cynthia Gibert, Maria C. Rodriguez-Barradas, Matthew Bidwell Goetz, Roger J. Bedimo, Sheldon T. Brown, Amy C. Justice & Robert Dubrow. (2016) Time trends in cancer incidence in persons living with HIV/AIDS in the antiretroviral therapy era. AIDS 30:11, pages 1795-1806.
Crossref
Crossref
Nicholas I Paton, Wolfgang Stöhr, Lars Oddershede, Alejandro Arenas-Pinto, Simon Walker, Mark Sculpher & David T Dunn. (2016) The Protease Inhibitor Monotherapy Versus Ongoing Triple Therapy (PIVOT) trial: a randomised controlled trial of a protease inhibitor monotherapy strategy for long-term management of human immunodeficiency virus infection. Health Technology Assessment 20:21, pages 1-158.
Crossref
Crossref
Daniel J. FellerBruce D. Agins. (2016) The Dissociation Between Viral Load Suppression and Retention in Care. AIDS Patient Care and STDs 30:3, pages 103-105.
Crossref
Crossref
Alejandro Arenas-Pinto, Ana Milinkovic, Dimitra Peppa, Anna McKendry, Mala Maini & Richard Gilson. (2015) Systemic inflammation and residual viraemia in HIV-positive adults on protease inhibitor monotherapy: a cross-sectional study. BMC Infectious Diseases 15:1.
Crossref
Crossref
Carmela Pinnetti, Simona Di Giambenedetto, Franco Maggiolo, Massimiliano Fabbiani, Gaetana Sterrantino, Alessandra Latini, Patrizia Lorenzini, Adriana Ammassari, Laura Loiacono, Rita Bellagamba, Evangelo Boumis, Roberto Cauda, Andrea Antinori & Mauro Zaccarelli. (2015) Switching to Coformulated Rilpivirine/Emtricitabine/Tenofovir in Virologically Suppressed Patients. JAIDS Journal of Acquired Immune Deficiency Syndromes 70:4, pages e147-e150.
Crossref
Crossref
Arin Dutta, Catherine Barker & Ashley Kallarakal. (2015) The HIV Treatment Gap: Estimates of the Financial Resources Needed versus Available for Scale-Up of Antiretroviral Therapy in 97 Countries from 2015 to 2020. PLOS Medicine 12:11, pages e1001907.
Crossref
Crossref
P.G. Clay, S. Nag, C.M. Graham & S. Narayanan. (2015) Meta-Analysis of Studies Comparing Single and Multi-Tablet Fixed Dose Combination HIV Treatment Regimens. Medicine 94:42, pages e1677.
Crossref
Crossref
Kristen Andreatta, Rima Kulkarni, Michael E. Abram, Thai Nguyen, Huyen Cao, Michael D. Miller & Kirsten L. White. (2015) Baseline Antiretroviral Resistance Mutations and Treatment-Emergent Resistance in HIV-1 RNA-Suppressed Patients Switching to EVG/COBI/FTC/TDF or Continuing on Their PI-, NNRTI-, or RAL-Based Regimen. JAIDS Journal of Acquired Immune Deficiency Syndromes 68:5, pages 519-526.
Crossref
Crossref
P Gantner, S Reinhart, M Partisani, M Baldeyrou, M-L Batard, C Bernard-Henry, C Cheneau, E de Mautort, M Priester, S Fafi-Kremer, P Muret & D Rey. (2015) Switching to emtricitabine, tenofovir and rilpivirine as single tablet regimen in virologically suppressed HIV-1-infected patients: a cohort study. HIV Medicine 16:2, pages 132-136.
Crossref
Crossref
Jean B NachegaOlalekan A UthmanKarl PeltzerLindsey A RichardsonEdward J MillsKofi AmekudziAlice Ouédraogo. (2015) Association between antiretroviral therapy adherence and employment status: systematic review and meta-analysis. Bulletin of the World Health Organization 93:1, pages 29-41.
Crossref
Crossref
Miguel A. Ramiro & Josep M. Llibre. (2014) Legal, ethical, and economic implications of breaking down once-daily fixed-dose antiretroviral combinations into their single components for cost reduction. Enfermedades Infecciosas y Microbiología Clínica 32:9, pages 598-602.
Crossref
Crossref
Beatriz Jiménez-Montero, José Beceiro, M. Isabel de José-Gómez, M. Isabel González-Tomé, Dolores Gurbindo-Gutierrez, Jorge Martínez-Pérez, M. José Mellado-Peña, M. Luisa Navarro-Gómez, Miguel A. Roa-Francia, Pablo Rojo-Conejo, Jesús Saavedra-Lozano, Santiago Jiménez de Ory & José T. Ramos-Amador. (2014) Once-daily Antiretroviral Therapy in a Cohort of HIV-Infected Children and Adolescents. Pediatric Infectious Disease Journal 33:10, pages 1052-1054.
Crossref
Crossref
Parya Saberi, Torsten B. Neilands & Mallory O. Johnson. (2013) Association between Dog Guardianship and HIV Clinical Outcomes. Journal of the International Association of Providers of AIDS Care (JIAPAC) 13:4, pages 300-304.
Crossref
Crossref
Margaret T. May, Mark Gompels, Valerie Delpech, Kholoud Porter, Chloe Orkin, Stephen Kegg, Phillip Hay, Margaret Johnson, Adrian Palfreeman, Richard Gilson, David Chadwick, Fabiola Martin, Teresa Hill, John Walsh, Frank Post, Martin Fisher, Jonathan Ainsworth, Sophie Jose, Clifford Leen, Mark Nelson, Jane Anderson & Caroline Sabin. (2014) Impact on life expectancy of HIV-1 positive individuals of CD4+ cell count and viral load response to antiretroviral therapy. AIDS 28:8, pages 1193-1202.
Crossref
Crossref
Jean B. Nachega, Jean-Jacques Parienti, Olalekan A. Uthman, Robert Gross, David W. Dowdy, Paul E. Sax, Joel E. Gallant, Michael J. Mugavero, Edward J. Mills & Thomas P. Giordano. (2014) Lower Pill Burden and Once-Daily Antiretroviral Treatment Regimens for HIV Infection: A Meta-Analysis of Randomized Controlled Trials. Clinical Infectious Diseases 58:9, pages 1297-1307.
Crossref
Crossref
Torsak BunupuradahApirudee PanthongPope KosalaraksaJiratchaya WongsabutThanyawee PuthanakitPagakrong LumbiganonThongsuai ChuanjaroenChanasda SopharakThanitta UdompanitWasana PrasitsuebsaiChitsanu PancharoenJintanat Ananworanich. (2014) Simplifying Antiretroviral Therapy to Lopinavir/Ritonavir Monotherapy Did Not Improve Quality of Life and Therapy Adherence in Pretreated HIV-Infected Children. AIDS Research and Human Retroviruses 30:3, pages 260-265.
Crossref
Crossref
A Falkenhagen, M Ameli, S Asad, S E Read & S Joshi. (2013) A novel gene therapy strategy using secreted multifunctional anti-HIV proteins to confer protection to gene-modified and unmodified target cells. Gene Therapy 21:2, pages 175-187.
Crossref
Crossref
Frank J. Palella, Martin Fisher, Pablo Tebas, Brian Gazzard, Peter Ruane, Jan Van Lunzen, David Shamblaw, Jason Flamm, Ramin Ebrahimi, Danielle Porter, Kirsten White, Jason Hindman, Elizabeth Elbert, Shampa De-Oertel & Todd Fralich. (2014) Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants. AIDS 28:3, pages 335-344.
Crossref
Crossref
Katy A. van Galen, Jeannine F. Nellen & Pythia T. Nieuwkerk. (2014) The Effect on Treatment Adherence of Administering Drugs as Fixed-Dose Combinations versus as Separate Pills: Systematic Review and Meta-Analysis. AIDS Research and Treatment 2014, pages 1-6.
Crossref
Crossref
Edward Broughton, Danilo Nunez & Indira Moreno. (2014) Cost-Effectiveness of Improving Health Care to People with HIV in Nicaragua. Nursing Research and Practice 2014, pages 1-6.
Crossref
Crossref
Danielle P. Porter & Bill Guyer. 2013. Successful Strategies for the Discovery of Antiviral Drugs. Successful Strategies for the Discovery of Antiviral Drugs
482
508
.
J. A. Kieran, S. Schmitz, A. O'Leary, C. Walsh, C. Bergin, S. Norris & M. G. Barry. (2013) Reply to Calcagno et al. Clinical Infectious Diseases 56:11, pages 1678-1679.
Crossref
Crossref
David B. Hanna, Kate Buchacz, Kelly A. Gebo, Nancy A. Hessol, Michael A. Horberg, Lisa P. Jacobson, Gregory D. Kirk, Mari M. Kitahata, P. Todd Korthuis, Richard D. Moore, Sonia Napravnik, Pragna Patel, Michael J. Silverberg, Timothy R. Sterling, James H. Willig, Bryan Lau, Keri N. Althoff, Heidi M. Crane, Ann C. Collier, Hasina Samji, Jennifer E. Thorne, M. John Gill, Marina B. Klein, Jeffrey N. Martin, Benigno Rodriguez, Sean B. Rourke, Stephen J. Gange, A. Benson, Ronald J. Bosch, Ann C. Collier, Stephen Boswell, Chris Grasso, Ken Mayer, Robert S. Hogg, Richard Harrigan, Julio Montaner, Angela Cescon, John T. Brooks, Kate Buchacz, Kelly A. Gebo, Richard D. Moore, Benigno Rodriguez, Michael A. Horberg, Michael J. Silverberg, Jennifer E. Thorne, James J. Goedert, Lisa P. Jacobson, Marina B. Klein, Sean B. Rourke, Ann Burchell, Anita R. Rachlis, Robert F. Hunter-Mellado, Angel M. Mayor, M. John Gill, Steven G. Deeks, Jeffrey N. Martin, Michael S. Saag, Michael J. Mugavero, James Willig, Joseph J. Eron, Sonia Napravnik, Mari M. Kitahata, Heidi M. Crane, Amy C. Justice, Robert Dubrow, David Fiellin, Timothy R. Sterling, David Haas, Sally Bebawy, Megan Turner, Stephen J. Gange, Kathryn Anastos, Richard D. Moore, Michael S. Saag, Stephen J. Gange, Mari M. Kitahata, Rosemary G. McKaig, Amy C. Justice, Aimee M. Freeman, Richard D. Moore, Aimee M. Freeman, Carol Lent, Aaron Platt, Mari M. Kitahata, Stephen E. Van Rompaey, Heidi M. Crane, Eric Webster, Liz Morton, Brenda Simon, Stephen J. Gange, Alison G. Abraham, Bryan Lau, Keri N. Althoff, Jinbing Zhang, Jerry Jing, Elizabeth Golub, Shari Modur, David B. Hanna, Peter Rebeiro, Cherise Wong & Adell Mendes. (2013) Trends and Disparities in Antiretroviral Therapy Initiation and Virologic Suppression Among Newly Treatment-Eligible HIV-Infected Individuals in North America, 2001–2009. Clinical Infectious Diseases 56:8, pages 1174-1182.
Crossref
Crossref
K. Rivet Amico & Catherine Orrell. (2013) Antiretroviral Therapy Adherence Support. Journal of the International Association of Providers of AIDS Care (JIAPAC) 12:2, pages 128-137.
Crossref
Crossref
Helen Bygrave, Judith Mtangirwa, Kwenzakwenkosi Ncube, Nathan Ford, Katharina Kranzer & Dhodho Munyaradzi. (2012) Antiretroviral Therapy Outcomes among Adolescents and Youth in Rural Zimbabwe. PLoS ONE 7:12, pages e52856.
Crossref
Crossref
B Mann, M-J Milloy, T Kerr, R Zhang, J Montaner & E Wood. (2012) Improved adherence to modern antiretroviral therapy among HIV-infected injecting drug users. HIV Medicine 13:10, pages 596-601.
Crossref
Crossref
Jean B. Nachega, Olalekan A. Uthman, Jean Anderson, Karl Peltzer, Sarah Wampold, Mark F. Cotton, Edward J. Mills, Yuh-Shan Ho, Jeffrey S.A. Stringer, James A. McIntyre & Lynne M. Mofenson. (2012) Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries. AIDS 26:16, pages 2039-2052.
Crossref
Crossref
Jean B. Nachega, Alice J. Hsu, Olalekan A. Uthman, Anne Spinewine & Paul A. Pham. (2012) Antiretroviral therapy adherence and drug–drug interactions in the aging HIV population. AIDS 26:Supplement S1, pages S39-S53.
Crossref
Crossref
Emanuele Focà, Diego Ripamonti, Davide Motta & Carlo Torti. (2012) Unboosted Atazanavir for Treatment of HIV Infection. Drugs 72:9, pages 1161-1173.
Crossref
Crossref
Michael H Chung. (2011) Antiretroviral adherence interventions: what works and what does not work. Future Virology 6:11, pages 1263-1265.
Crossref
Crossref